The purpose of this study is to determine whether induction of labour with vaginal misoprostol application will result in fewer caesarean deliveries than vaginal PGE2 gel application in women with premature rupture of membranes at Term...
Date First Received: July 19, 2006
Last Updated: July 2, 2008
Verified by: Nilratan Sircar Medical College, June 2008
Clinical Trial Phase: Phase 4 | Start Date: August 2006
Overall Status: Recruiting
Estimated Enrollment: 1300
Brief Summary
Condition Keyword(s):
Intervention(s):
The purpose of this study is to determine whether induction of labour with vaginal misoprostol application will result in fewer caesarean deliveries than vaginal PGE2 gel application in women with premature rupture of membranes at Term.
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Study Primary Completion Date: August 2012
Intervention(s) in this Clinical Trial
- Drug: Misoprostol in arm A & PGE2 Gel in arm B
- In arm A Intravaginal Misoprostol is applied 25 microgram 4 hourly a maximum of five doses. In arm B PGE2 gel is applied at 6 hour interval with a maximum of 2 doses.
Arms, Groups and Cohorts in this Clinical Trial
- Active Comparator: misoprostol -A & PGE2 gel-B
- participants are assigned to one of two arms for the duration of the study In arm A of study induction of labour is done by intravaginal misoprostol & in arm B, induction of labour is done by PGE2 gel application in posterior fornix and the outcomes will be compared
Outcome Measures for this Clinical Trial
Primary Measures
- Caesarean Section rate
- Time Frame: 48 hours
Safety Issue?: No
- Time Frame: 48 hours
Secondary Measures
- Induction delivery time,
- Time Frame: 48 hours
Safety Issue?: No
- Time Frame: 48 hours
- Neonatal & maternal infectious morbidity
- Time Frame: till discharge from hospital or death
Safety Issue?: No
- Time Frame: till discharge from hospital or death
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Premature rupture of membranes at 37 or more weeks
- Single live fetus in cephalic presentation
Exclusion Criteria:
- Women in labour
- Women with contraindication of induction of labour
- Women with previous caesarean section or uterine surgery
Gender Eligibility for this Clinical Trial: Female
Minimum Age for this Clinical Trial: N/A
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Sponsor Information
Lead Sponsor: Nilratan Sircar Medical College
Overall Clinical Trial Officials and Contacts
Snehamay Chaudhuri, MBBS,MD.DNB Principal Investigator Nilratan Sircar Medical College , Kolkata, West bengal , India
Overall Contact: Snehamay Chaudhuri, MBBS,MD,DNB 91-33-23537900 snehamay_chaudhuri_dr@yahoo.com
Additional Information
Information obtained from ClinicalTrials.gov on September 05, 2008
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00355303
Study ID Number: 2-Chaudhuri
ClinicalTrials.gov Identifier: NCT00355303
Health Authority: India: Ministry of Health
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.